A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. (Q48215611)

9 February 2018

title

A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. (English)

1 reference

9 February 2018

secondary progressive multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

author name string

J Furby

1

1 reference

9 February 2018

T Hayton

2

1 reference

9 February 2018

D Altmann

3

1 reference

9 February 2018

R Brenner

4

1 reference

9 February 2018

J Chataway

5

1 reference

9 February 2018

K J Smith

6

1 reference

9 February 2018

D H Miller

7

1 reference

9 February 2018

R Kapoor

8

1 reference

9 February 2018

publication date

1 May 2010

1 reference

9 February 2018

published in

Journal of Neurology

1 reference

9 February 2018

volume

257

1 reference

9 February 2018

issue

9

1 reference

9 February 2018

page(s)

1508-1516

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-010-5563-y

exact match

0 references

cites work

Eight-year follow-up study of brain atrophy in patients with MS.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5563-Y

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5563-Y

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5563-Y

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5563-Y

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes

21 January 2018

1 reference

12 December 2020

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

12 December 2020

Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial

1 reference

12 December 2020

Gray matter atrophy in multiple sclerosis: a longitudinal study

1 reference

12 December 2020

The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology.

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study

1 reference

12 December 2020

Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans.

1 reference

12 December 2020

Multimodal image coregistration and partitioning--a unified framework.

1 reference

12 December 2020

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

1 reference

12 December 2020

One year follow up study of primary and transitional progressive multiple sclerosis

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

12 December 2020

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

12 December 2020

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

12 December 2020

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

1 reference

12 December 2020

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter

1 reference

12 December 2020

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

1 reference

12 December 2020

The contribution of demyelination to axonal loss in multiple sclerosis.

1 reference

12 December 2020

Ventricular enlargement in MS: one-year change at various stages of disease.

1 reference

12 December 2020

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis

1 reference

12 December 2020

The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite

1 reference

12 December 2020

Magnetic resonance imaging measures of brain atrophy in multiple sclerosis

1 reference

12 December 2020

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts

1 reference

12 December 2020

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

12 December 2020

Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI

1 reference

12 December 2020

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

12 December 2020

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

1 reference

12 December 2020

Spinal cord atrophy and disability in multiple sclerosis

1 reference

12 December 2020

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

1 reference

12 December 2020

The relationship of brain and cervical cord volume to disability in clinical subtypes of multiple sclerosis: a three-dimensional MRI study.

1 reference

12 December 2020

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.

1 reference

12 December 2020

Spinal cord atrophy and disability in MS: A longitudinal study

1 reference

12 December 2020

Gray matter atrophy is related to long-term disability in multiple sclerosis

1 reference

12 December 2020

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

1 reference

12 December 2020

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

1 reference

12 December 2020

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

1 reference

12 December 2020

10.1007/S00415-010-5563-Y

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

20437181

1 reference

9 February 2018